In vivo 1 and in vitro 2 animal studies have shown that local anaesthetics produce dose-related depression of cardiac output or negative inotropic action with minimal changes in peripheral vascular resistance. Although the electrophysiological basis of local anaesthetic action is block of sodium channels, the mechanisms of myocardial depression may involve additional actions indirectly related to the regulation of intracellular calcium such as Ca 2; entry into the cell or Ca 2; release from the sarcoplasmic reticulum.
In vivo 1 and in vitro 2 animal studies have shown that local anaesthetics produce dose-related depression of cardiac output or negative inotropic action with minimal changes in peripheral vascular resistance. Although the electrophysiological basis of local anaesthetic action is block of sodium channels, the mechanisms of myocardial depression may involve additional actions indirectly related to the regulation of intracellular calcium such as Ca 2; entry into the cell or Ca 2; release from the sarcoplasmic reticulum.
Mepivacaine, an amide local anaesthetic agent with potency similar to lidocaine, has been reported to show clinical effects similar to lidocaine, although it is closely related in chemical structure to bupivacaine. Although the negative inotropic effect of mepivacaine has been reported in an in vivo study, 1 direct myocardial depression has not yet been defined. Therefore, the purpose of this study was to determine the degree and mechanisms of direct myocardial depression produced by mepivacaine.
Methods and results

EXPERIMENT WITH NORMAL K
;
TYRODE'S SOLUTION
According to a procedure approved by the Yonsei University College of Medicine Animal Research Committee, the right ventricular papillary muscle was removed from female guinea pigs (300-400 g) or Sprague-Dawley rats (300-400 g) after intraperitoneal pentobarbital sodium injection (50 mg kg
91
). The tendinous end of the muscle was attached by a strut to a GRASS FT03 force transducer. The bath was superfused at 37ЊC at a rate of 8 ml min 91 with normal Tyrode's solution (mmol litre
: Na 143, K 5, Ca 2, Cl 127, MgSO 4 1.2, HCO 3 9 25, glucose 11, Ethylenediaminetetraacetic acid (EDTA) 0.1) bubbled with 95% oxygen/5% carbon dioxide maintaining mean pH (SD) at 7.4 (0.5). The muscles were field-stimulated by a GRASS S44 stimulator (GRASS Instruments, Quincy, MA, U.S.A.).
Membrane potential and its rate of rise during the action potential (dV/dt max) was monitored by a conventional 3 M KCl-filled glass microelectrode (10-20 M⍀) attached to a WPIVF-1 preamplifier. In rat experiments, the contractile response to 100 mol litre 91 mepivacaine in normal Tyrode's solution only was observed. As rat papillary muscle showed progressive deterioration of contractility over time, time control experiments were performed separately to those of mepivacaine administration.
Whereas 
RAPID COOLING CONTRACTURE EXPERIMENTS
After the 15-min rest at 37ЊC, rapid cooling was induced by perfusion at a flow rate of about 50 ml min 91 with 0ЊC normal Tyrode's solution (:5ЊC achieved within 1.5 s) in which 95% oxygen/5% carbon dioxide was bubbled. Following the measurement of RS rapid cooling contracture, the chamber was changed to normal Tyrode's solution at 37ЊC. After full rewarming to 37 ЊC, stimulation at 0.1 Hz, followed by 1 and 2 Hz stimulation rates, was sequentially applied until maximal and stable contractions were elicited after 2 Hz. Rapid cooling was induced again. Following control measurements, muscles were exposed to mepivacaine 100 mol litre 91 for 15 min at 37 ЊC before eliciting the rapid cooling contracture.
After 15-min rest, there was no change in RS rapid cooling contracture with mepivacaine 100 mol litre
91
. Peak force at 2 Hz contraction was diminished to about 58% of control by mepivacaine 100 mol litre 91 , while contracture was depressed from 5.11 to 3.86 mN mm 92 (about 70% of control). Time to peak contracture remained unchanged (control: 13.6 s, 100 mol litre 91 14.5 s). In force studies, mean cross-sectional areas were 0.81 (0.29) (mean (SD), n:40) and 0.88 (0.45) mm 2 (mean (SD), n:13) in guinea pigs and rats, respectively.
Repeated measures of analysis of variance (ANOVA) followed by Fisher PLSD multiple range test was applied to test for significant differences in the stimulation rates and among the mepivacaine concentrations. A P value :0.05 was considered significant.
Comment
Moderate depression by mepivacaine of cardiac output and stroke volume (about 15%) with little change in systemic vascular resistance has been reported in an in vivo animal study. Although etidocaine and bupivacaine caused more marked depression of cardiac output (about 50% and 100%, respectively), lidocaine showed modest depression at the same dose. 1 In the present study, mepivacaine 50 mol litre 91 caused an approximate 40% depression of peak force, which was comparable to that of lidocaine 40 mol litre 91 in a previous guinea pig papillary muscle study. 2 Our results in normal Tyrode's solution demonstrated that depression of myocardial contractility and frequency-dependent block of dV/dt max are more pronounced at higher (2, 3 Hz) stimulation rates with mepivacaine 100 mol litre
91
. The block of Na ; currents at higher frequencies may account in part for the more decreased contractile depression observed in guinea pig ventricular muscle at 2 and 3 Hz.
The Cerebral symptoms suggesting systemic intoxication during caudal analgesia have been reported to be associated with a mean mepivacaine concentration in blood of 6.27 g ml 91 (25.48 mol litre
). 4 If we assume that the protein binding of mepivacaine at this concentration is approximately 40%, 5 the free plasma concentration will be estimated as 3.76 g ml 91 (15.28 mol litre
). As the therapeutic concentrations of mepivacaine observed after a lumbar extradural administration range from 4 to 6 g ml 91 (5.69-8.54 mol litre 91 if we assume 65% protein binding at this range of concentration), 6 this free drug concentration is unlikely to cause myocardial depression. However, in the case of inadvertent administration of mepivacaine, the transient increase in blood concentration may produce cardiac contractile depression if we consider peak blood concentration of lidocaine to be about 30 g ml 91 (128 mol litre 91 ) when 3 mg kg 91 was injected i.v. 
